Maria Febbraio

Maria Febbraio

Auto-generated profile, based on publicly available information

Maria Febbraio

Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2007 in The International Journal of Biochemistry & Cell Biology
Verified
Journal Article
Closed access
MFMaria Febbraio
Maria Febbraio
RSRoy L. Silverstein
Roy L. Silverstein

7 December 2007 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
SKSai Kuchibhotla
Sai Kuchibhotla
DVDifernando Vanegas
Difernando Vanegas
DKDavid J. Kennedy
David J. Kennedy
EGElla Guy
Ella Guy
GNGeorge Nimako
George Nimako
MFMaria Febbraio
Maria Febbraio
The role of scavenger receptors in atherogenesis is controversial as a result of conflicting reports and a recent hypothesis suggesting that scavenger receptor absence would enhance the pro-inflammatory, pro-atherogenic milieu. This study addresses the effect of combined absence of scavenger receptors CD36 and SRA I/II on atherosclerosis lesion development in the apolipoprotein E knock-out (apoE°) model. We created background-related strains of apoE°, scavenger receptor A I/II knock-out (SRA°)/apoE°, CD36 knock-out (CD36°)/apoE°, and CD36°/SRA°/apoE° mice that were >99% C57Bl/6. Four-week-old mice were fed a Western diet for 12 weeks and were assessed for lesion burden/morphology, risk factors for atherosclerosis, inflammatory mediators, and macrophage function. There was a 61 and 74% decrease in total aortic lesion area in CD36°/apoE° males and females, respectively, compared with apoE° controls. The absence of SRA was protective (32% decrease in lesion) in female mice. The combined absence of CD36 and SRA provided no further protection in either gender. Macrophages from mice lacking CD36 had decreased pro-inflammatory characteristics and less migration to a pro-inflammatory stimulus. Plasma levels of cytokines/chemokines showed that CD36°/apoE° and CD36°/SRA°/apoE° mice had a less pro-inflammatory phenotype compared with apoE° and SRA°/apoE° mice. Oblivious mice in the apoE° background ruled out potential ‘passenger gene’ effects in the case of CD36. These results provide new insights into the pro-atherogenic mechanisms of CD36 by implicating processes other than modified lipoprotein uptake.

18 November 2010 in Cardiovascular Research
Verified
Journal Article
Open access
PDF file
DKDavid J. Kennedy
David J. Kennedy
SKSai Kuchibhotla
Sai Kuchibhotla
KWKristen M. Westfall
Kristen M. Westfall
RSRoy L. Silverstein
Roy L. Silverstein
RMRichard E. Morton
Richard E. Morton
MFMaria Febbraio
Maria Febbraio
Obesity and hyperlipidaemia are associated with insulin resistance (IR); however, the mechanisms responsible remain incompletely understood. Pro-atherogenic hyperlipidaemic states are characterized by inflammation, oxidant stress, and pathophysiologic oxidized lipids, including ligands for the scavenger receptor CD36. Here we tested the hypothesis that the absence of CD36 protects mice from IR associated with diet-induced obesity and hyperlipidaemia. Adipose tissue from CD36−/− mice demonstrated a less inflammatory phenotype and improved insulin signalling in vivo and at the level of the adipocyte and macrophage. The pathophysiologic ligand oxidized low-density lipoprotein (oxLDL) activated c-Jun N-terminal kinase (JNK) and disrupted insulin signalling in both adipocytes and macrophages in a CD36-dependent manner. Macrophages isolated from CD36−/− mice after high-fat diet feeding elicited less JNK activation and inhibition of insulin signalling in adipocytes after co-culture compared with wild-type macrophages. These data suggest that a CD36-dependent inflammatory paracrine loop between adipocytes and macrophages facilitates chronic inflammation and contributes to IR common in obesity and dyslipidaemia.

1 December 2004 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MFMaria Febbraio
Maria Febbraio
EGElla Guy
Ella Guy
RSRoy L. Silverstein
Roy L. Silverstein
Objective— CD36 is expressed on multiple cell types and has numerous functions, a subset of which can impact on atherogenesis. In previous work, we demonstrated that CD36 absence was protective against lesion formation. The current objective was to determine whether absence of macrophage CD36 alone was protective. Methods and Results— Lethal irradiation and stem cell transfer were used to create chimeric mice that did or did not express macrophage CD36 in the context of the Apo E-null model of atherosclerosis. After engraftment, mice were fed a Western diet for 12 weeks. White cell counts, plasma levels of lipoproteins, triacylglycerol, and nonesterified fatty acids were determined, and glucose tolerance tests were preformed. Lesion area was assessed quantitatively after oil red O staining. Mice lacking CD36 in macrophages alone were profoundly protected against atherosclerosis (88.1% reduction of lesion area throughout the aortic tree). Re-introduction of macrophage CD36 resulted in a 2.11-fold increase in lesion area. There were no differences in engraftment, macrophage recruitment, glucose tolerance, weight, and total, low-density lipoprotein, and high-density lipoprotein cholesterol among the groups. Lesions contained similar percent macrophage antigen-positive area. Conclusion— Protection in this model is primarily caused by loss of CD36 macrophage function.

1 October 2009 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
DKDavid J. Kennedy
David J. Kennedy
SKSai D. Kuchibhotla
Sai D. Kuchibhotla
EGElla Guy
Ella Guy
YPYoung Mi Park
Young Mi Park
GNGeorge Nimako
George Nimako
MFMaria Febbraio
Maria Febbraio
Objective— CD36 has been shown to play a role in atherosclerosis in the apolipoprotein E-knockout (apoEo) mouse. We observed no difference in aortic lesion area between Western diet (WD)-fed LDLRo and LDLRo/CD36o mice. The objective was to understand the mechanism of CD36-dependent atherogenesis. Methods and Results— ApoEo mice transplanted with bone marrow from LDLRo/CD36o mice had significantly less aortic lesion compared with those transplanted with LDLRo marrow. Reciprocal macrophage transfer into hyperlipidemic apoEo and LDLRo animals showed that foam cell formation induced by in vivo modified lipoproteins was dependent on the lipoprotein, not macrophage type. LDLRo and LDLRo/CD36o mice were fed a cholesterol-enriched diet (HC), and we observed significant lesion inhibition in LDLRo/CD36o mice. LDL/plasma isolated from HC-fed LDLRo mice induced significantly greater jnk phosphorylation, cytokine release, and reactive oxygen species secretion than LDL/plasma from WD-fed LDLRo mice, and this was CD36-d... In the LDLR knockout mouse model of atherogenesis, dietary cholesterol played a role in CD36-dependent lesion burden. Addition of cholesterol resulted in increased inflammation and release of reactive oxygen species by macrophages, which was abrogated in the absence of CD36. A proinflammatory milieu may be essential to creation of CD36-specific proatherogenic ligands.

16 March 2007 in Malaria Journal
Verified
Journal Article
Open access
PDF file
MCMargarida Cunha-Rodrigues
Margarida Cunha-Rodrigues
SPSílvia Portugal
Sílvia Portugal
MFMaria Febbraio
Maria Febbraio
MMMaria M Mota
Maria M Mota
Background: Adhesion of Plasmodium-infected red blood cells (iRBC) to different host cells, ranging from endothelial to red blood cells, is associated to malaria pathology. In vitro studies have shown the relevance of CD36 for adhesion phenotypes of Plasmodium falciparum iRBC such as sequestration, platelet mediated clumping and non-opsonic uptake of iRBC. Different adhesion phenotypes involve different host cells and are associated with different pathological outcomes of disease. Studies with different human populations with CD36 polymorphisms failed to attribute a clear role to CD36 expression in human malaria. Up to the present, no in vivo model has been available to study the relevance of different CD36 adhesion phenotypes to the pathological course of Plasmodium infection. Methods: Using CD36-deficient mice and their control littermates, CD36 bone marrow chimeric mice, expressing CD36 exclusively in haematopoietic cells or in non-haematopoietic cells, were generated. Irradiated CD36-/- and wild type mice were also reconstituted with syngeneic cells to control for the effects of irradiation. The reconstituted mice were infected with Plasmodium berghei ANKA and analysed for the development of blood parasitaemia and neurological symptoms. Results: All mice reconstituted with syngeneic bone marrow cells as well as chimeric mice expressing CD36 exclusively in non-haematopoietic cells died from experimental cerebral malaria between day 6 and 12 after infection. A significant proportion of chimeric mice expressing CD36 only in haematopoietic cells did not die from cerebral malaria. Conclusion: The analysis of bone marrow chimeric mice reveals a dual role of CD36 in P. berghei ANKA infection. Expression of CD36 in haematopoietic cells, most likely macrophages and dendritic cells, has a beneficial effect that is masked in normal mice by adverse effects of CD36 expression in non-haematopoietic cells, most likely endothelial cells.